Despite the rapid adoption of its healthcare-oriented software and data analysis services, Wall Street has clearly soured on Veeva Systems' (NYSE: VEEV) shares this year. Over the course of 2022, this former high-flying stock has given back a large chunk of its stellar gains over the prior two years in response to a tougher economic climate, geopolitical unrest, and a general flight to safety by nervous investors. 

Is this falling knife worth catching? Here is the bull-vs.-bear argument for buying this beaten-down growth stock right now.

Image Source: Getty Images.

Continue reading

Source Fool.com